Did you know about this possible new treatment, seralutinib?
Following positive outcomes in Phase 2, Gossamer is preparing to initiate Phase 3, aiming to provide improved options for the PH community. Gossamer Bio intends to commence a Phase 3 PAH trial for seralutinib this year.
The company recently announced a corporate restructuring to concentrate on developing seralutinib. They are committed to advancing this clinical trial to benefit those affected by PH.
You can read more of this article by our PH News team here.
Did you know about this possible new treatment, seralutinib? What insights did you gain from this informative and inspiring article?
Log in to reply.